Regulatory effects of the AMPKα-SIRT1 molecular pathway on insulin resistance in PCOS mice: An in vitro and in vivo...

Area of Science:

• Endocrinology
• Reproductive Biology
• Molecular Medicine

Background:

• Polycystic ovary syndrome (PCOS) is a complex endocrine disorder associated with insulin resistance (IR) and reproductive dysfunction.
• The molecular mechanisms underlying PCOS pathogenesis, particularly the role of the AMPKα-SIRT1 pathway, require further elucidation.

Purpose of the Study:

• To investigate the correlation between the AMPKα-SIRT1 pathway and IR in a PCOS mouse model.
• To identify potential therapeutic targets for PCOS by exploring the pathway's role in pathogenesis.

Main Methods:

• In vitro study using human granulosa KGN cells and in vivo study using a DHEA-induced PCOS mouse model.
• Administration of AICAR (activator) and Compound C (inhibitor) to assess AMPKα-SIRT1 pathway modulation and its effects on IR.

Main Results:

• DHEA treatment decreased AMPKα and SIRT1 expression in KGN cells.
• PCOS mice exhibited significant IR, reduced granulosa cell numbers, disordered arrangement, increased immature follicles, and down-regulated AMPKα-SIRT1 pathways.
• AICAR treatment upregulated the AMPKα-SIRT1 pathway, improving IR, an effect blocked by Compound C.

Conclusions:

• The AMPKα-SIRT1 molecular pathway is implicated in the pathogenesis of IR in PCOS.
• Modulation of the AMPKα-SIRT1 pathway presents a potential therapeutic strategy for improving metabolic and reproductive functions in PCOS.